Will New FDA Meeting on Avandia Prompt Withdrawal of Drug?Will New FDA Meeting on Avandia Prompt Withdrawal of Drug?

The FDA has announced that 2 of its panels will discuss the reanalysis of the controversial RECORD trial with the much-maligned diabetes drug rosiglitazone in June. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news